National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 49001-49002 [2012-19994]
Download as PDF
Federal Register / Vol. 77, No. 158 / Wednesday, August 15, 2012 / Notices
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Neurological Sciences
Training Initial Review Group; NST–1
Subcommittee.
Date: September 10–11, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Churchill Hotel, 1914 Connecticut
Avenue NW., Washington, DC 20009.
Contact Person: Raul A. Saavedra, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS, NSC, 6001 Executive
Blvd., Suite 3208, MSC 9529, Bethesda, MD
20892–9529, 301–496–9223,
saavedrr@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Agenda: Achieving Widespread HPV
Vaccine Uptake.
Place: Crystal City Marriott at Reagan
National Airport, 1999 Jefferson Davis
Highway, Salon BC, Arlington, VA 22202.
Contact Person: Abby B. Sandler, Ph.D.,
Executive Secretary, Chief, Institute Review
Office, Office of the Director, 6116 Executive
Blvd., Suite 220, MSC 8349, National Cancer
Institute, NIH, Bethesda, MD 20892–8349,
(301) 451–9399, sandlera@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/pcp/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: August 9, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–19995 Filed 8–14–12; 8:45 am]
Dated: August 8, 2012.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2012–20073 Filed 8–14–12; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Center for Scientific Review; Notice of
Closed Meetings
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
srobinson on DSK4SPTVN1PROD with NOTICES
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
President’s Cancer Panel.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: President’s Cancer
Panel.
Date: September 13, 2012.
Time: 8:30 a.m. to 6 p.m.
VerDate Mar<15>2010
17:49 Aug 14, 2012
Jkt 226001
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Stem Cells, Heart Regeneration,
Congenital Heart Defect and Cardiac Valve
Disease.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
49001
Date: September 10, 2012.
Time: 2 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Yuanna Cheng, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138,
MSC 7814, Bethesda, MD 20892, (301)435–
1195, Chengy5@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Pain and Hearing.
Date: September 12–13, 2012.
Time: 8 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: John Bishop, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group, Biomaterials and Biointerfaces Study
Section.
Date: September 13–14, 2012.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Arlington Capital
View Hotel, 2850 South Potomac Avenue,
Arlington, VA 22202.
Contact Person: Joseph D Mosca, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5158,
MSC 7808, Bethesda, MD 20892, (301) 408–
9465, moscajos@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 9, 2012.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–19996 Filed 8–14–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
E:\FR\FM\15AUN1.SGM
15AUN1
49002
Federal Register / Vol. 77, No. 158 / Wednesday, August 15, 2012 / Notices
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIAID Investigator Initiated
Program Project Application (P01).
Date: September 26, 2012.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Fernwood (Rockledge Campus),
10401 Fernwood Rd., Room 2C07, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Kelly Y. Poe, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 6700–B
Rockledge Drive, MDS–7616, Bethesda, MD
20892–7616, 301–451–2639,
poeky@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 9, 2012.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–19994 Filed 8–14–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2012–0770]
Towing Safety Advisory Committee;
Meeting
Coast Guard, DHS.
Notice of Federal Advisory
Committee Meeting.
AGENCY:
ACTION:
The Towing Safety Advisory
Committee (TSAC) will meet on
September 19 and 20, 2012. On
September 19, the committee will meet
to discuss administrative matters and
then recess for the separate but
concurrent meetings of the four
subcommittees, ‘‘Recommendations for
the Prevention of Towing Vessel
Crewmember Falls Overboard’’,
‘‘Review and recommendations for the
revision of NVIC 1–95, Voluntary
Training Standards for Entry-Level
Personnel on Towing Industry Vessels’’,
srobinson on DSK4SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:49 Aug 14, 2012
Jkt 226001
‘‘Recommendations for the
Enhancement of Towing Vessel
Stability’’ and ‘‘Recommendations for
Safety Standards of Portable Facility
Vapor Control Systems Used for Marine
Operations.’’ The committee will
reconvene on September 20, 2012. The
meetings of the TSAC on both days and
the meeting of the subcommittees are
open to the public.
DATES: On Wednesday, September 19,
2012, from 8:30 a.m. to noon, the TSAC
will meet to discuss administrative
matters, and from 1:30 to 5 p.m. the four
subcommittees identified in the
‘‘Agenda’’ will meet. On Thursday,
September 20, 2012, the TSAC will meet
from 8:30 a.m. to 4:30 p.m. Please note
that these meetings may close early if
the committee has completed its
business. Oral comments may be made
at the September 20 meeting. Written
comments must be submitted no later
than September 10, 2012 by using one
of the methods listed below.
ADDRESSES: The meetings will be held at
the Federal Center South GSA Facility,
4735 East Marginal Way South, Seattle,
WA 98134.
If you are planning to attend the
meeting, you will be required to pass
through a security checkpoint. You will
be required to show state-issued photo
identification. Please arrive at least 30
minutes before the planned start of the
meeting in order to pass through
security.
For information on facilities or
services for individuals with disabilities
or to request special assistance at the
meeting, contact the individuals listed
in the FOR FURTHER INFORMATION
CONTACT section, as soon as possible.
To facilitate public participation, we
are inviting public comment on the
issues to be considered by the
committee as listed in the ‘‘Agenda’’
section below. Written comments must
be identified by Docket No. USCG–
2012–0770 and submitted by one of the
following methods:
• Federal Rulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Docket Management Facility
(M–30), U.S. Department of
Transportation, West Building Ground
Floor, Room W12–140, 1200 New Jersey
Avenue SE., Washington, DC 20590–
0001. We encourage use of electronic
submissions because security screening
may delay the delivery of mail.
• Fax: 202–493–2251.
• Hand Delivery: Same as mail
address above, between 9 a.m. and 5
p.m., Monday through Friday, except
Federal holidays. The telephone number
is 202–366–9329.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
• To avoid duplication, please use
only one of these methods. Instructions:
All submissions received must include
the words ‘‘Department of Homeland
Security’’ and the docket number of this
action. All comments submitted will be
posted on www.regulations.gov without
alteration and will contain any personal
information you provided. You may
review a Privacy Act notice regarding
our public dockets in the January 17,
2008, issue of the Federal Register (73
FR 3316).
Docket: For access to the docket to
read documents or comments related to
this notice, go to https://
www.regulations.gov, insert USCG–
2012–0770 in the Keyword ID box, press
Enter, and then click on the item you
are interested in viewing.
FOR FURTHER INFORMATION CONTACT:
Commander Rob Smith, Designated
Federal Officer (DFO) or Mr. Patrick
Mannion, Alternate Designated Federal
Officer (ADFO), TSAC; U.S. Coast Guard
Headquarters, CG–OES–2, Vessel and
Facilities Operating Standards Division;
telephone (202) 372–1439, fax (202)
372–1926, or email at:
Patrick.J.Mannion@USCG.MIL.
Notice of
this meeting is given under the Federal
Advisory Committee Act (FACA), 5
U.S.C. App. (Pub. L. 92–463). This
Committee is established in accordance
with and operates under the provisions
of the FACA. The Towing Safety
Advisory Committee provides advice
and recommendations to the
Department of Homeland Security on
matters relating to shallow-draft inland
and coastal waterway navigation and
towing safety. See 33 U.S.C. 1231a.
SUPPLEMENTARY INFORMATION:
Agenda
On September 19, 2012, from 8:30
a.m. to noon, the TSAC will meet to
discuss administrative matters such as
logistical support and review the
committee charter and bylaws. The
TSAC will recess at noon and starting at
1:30 p.m. the following four
subcommittees will convene to discuss
work remaining on their open task
statements. These subcommittees will
conclude their meetings at 5 p.m.
• Recommendations for the
Prevention of Towing Vessel
Crewmember Falls Overboard.
• Review and recommendations for
the revision of NVIC 1–95, Voluntary
Training Standards for Entry-Level
Personnel on Towing Industry Vessels.
• Recommendations for the
Enhancement of Towing Vessel
Stability.
• Recommendations for Safety
Standards of Portable Facility Vapor
E:\FR\FM\15AUN1.SGM
15AUN1
Agencies
[Federal Register Volume 77, Number 158 (Wednesday, August 15, 2012)]
[Notices]
[Pages 49001-49002]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-19994]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
[[Page 49002]]
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, NIAID Investigator Initiated
Program Project Application (P01).
Date: September 26, 2012.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: Fernwood (Rockledge Campus), 10401 Fernwood Rd., Room
2C07, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Kelly Y. Poe, Ph.D., Scientific Review Officer,
Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700-B Rockledge
Drive, MDS-7616, Bethesda, MD 20892-7616, 301-451-2639,
poeky@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: August 9, 2012.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-19994 Filed 8-14-12; 8:45 am]
BILLING CODE 4140-01-P